Anavex Life Sciences Corp (AVXL)

[falconer66a]

To create a market. No advertising costs.

Why would Anavex want to sell an unapproved drug at low prices or even at a loss?

Providing for the use of blarcamesine by hundreds of Australians with Alzheimer's under the newly-announced provisions by the Therapeutic Goods Administration would be the cheapest and most effective way to bring attention to the drug. Not a page or minute of paid-for advertising.

Then, when dozens of families start reporting good results, they will tell others. News reports will be written. Families and treated Alzheimer's patients will be interviewed.

That would create a diversity of forces pushing for full approval. Pretty clever, actually.

And, actually, the drug will not be "unapproved." With this announcement, the TGA has already given approval for sale and use, however so restricted presently.

If the TGA believed that blarcamesine for Alzheimer's was either unsafe or ineffective, would they have granted this new authorization? Of course not. This is just the first of ever more comprehensive "approvals" that shall ensue, both in Australia and elsewhere.